Peter Sullivan

Democratic states are pushing back on the Trump administration's rules for new Medicaid work requirements, warning that a chaotic rollout in the coming months could lead to even more people losing their coverage.

Why it matters: GOP lawmakers contend Medicare and Medicaid are rife with theft, but the new effort risks crossing the line into benefit cuts that could prompt political backlash in an election year.

Democrats argue Trump hasn't delivered meaningful results the way they did in 2022 through the Inflation Reduction Act.

A Senate plan to limit insulin costs in private insurance markets is getting new life after a key committee gave it bipartisan backing.

The first of what could be a slew of Trump health confirmation hearings will begin in July.

Customers could be on the hook for thousands of more dollars in costs, worsening the health affordability crisis.

Why it matters: It would mark the second straight year of double-digit premium increases in the individual market.

That doesn't mean controversies around vaccines and public health are over.

The latest Senate debate over a Trump health appointment kicks off Wednesday with a less polarizing nominee than some of the president's previous picks — but that doesn't mean controversies around vaccines and public health are over.

The House Ways and Means Committee is working on an overhaul of a law protecting patients from surprise medical bills, according to sources familiar with the discussions.